News

Scientists say they have identified urine bacteria which are linked to aggressive PCa. The discovery might provide new ways to spot and even prevent these dangerous tumours, experts hope. See more And scientists have hypothesised that if they found a way to get zinc into malignant cells that might be helpful. More here

Reducing barriers to screening in Black men

A research team is examining the links between neighbourhood factors, PSA testing and PCa mortality to improve access to screening in Black communities. More here And a programme to close the gap for Black men with PCa was announced by Prostate Cancer Research in August ’23. See more here  In partnership with Movember, Prostate Cancer UK is funding a study to help find out why Black men are at higher risk of PCa than other ethnic groups. And Prostate Cancer Research announced an initial £875k investment in finding answers to Black men’s higher risks of diagnosis and death. Black men are twice as likely to get PCa and 2.5 times more likely to die from it than White men. Five new projects launched to specifically tackle this inequity. And there’s more informatio for Black men in the wider column on our front page

Prostate Cancer Research has launched a website to empower people living with PCa to make better treatment decisions. Since launch there have been almost 100,000 visitors to the site. You can sign up here to share your experiences on The Infopool. And the Predict Prostate web tool helps you make decisions about PCa treatment. There is also a new tool here: It aims to help patients find out about the different tests and scans used to diagnose prostate cancer or to rule it out.

A hunt is on for 14,000 men who it’s estimated haven’t started PCa treatment due to the pandemic (Feb ’22). More here. Men are asked to answer three quick questions at this risk checker: The ‘Find the 14,000 men’ campaign by Prostate Cancer UK has been nominated for the NHS Communinications Initiative of the Year Award at the 2022 Health Service Journal Awards (Aug ’22).

A new radiation treatment was approved by the US FDA in March for certain patients with advanced PCa. It has been shown to help patients with advanced PCa live longer and maintain quality of life (Mar ’22). See more here

Ryan Edginton told us about the Raman Nanotheranostics (RaNT) team who are developing a new, all-in-one technology capable of diagnosing and treating cancers using a single device. See the video here

Screening for PCa could be possible within five years, says a leading UK expert  (Dec ’21). See more here

The Oxford-Astra Zeneca Covid vaccine technology has been used to design a jab that could treat cancer (Sept ’21). Sky News

Advanced PCa patients can take enzalutamide or abiraterone at home instead of going into hospital for chemotherapy, NHS England says. It will relieve pressure on the NHS. The drugs are smarter, kinder treatments and could extend the lives of many more men, it’s said (May ’20). More here. And a new treatment is being tested that could extend the lives of men with advanced prostate cancer, by killing cancer in the prostate despite the disease having spread. The nationwide Atlanta trial, at Imperial College London, was recruiting 918 newly-diagnosed men. More here

Scientists have created a “Trojan horse” that sneaks nanoparticles into cancer cells and causes them to self-destruct. The research is still in its early days, but the new method has already proved to be effective at killing cancer cells in a petri dish and reducing tumour growth in mice. See more